DAIICHI® UNVEILS NEW BRAND IDENTITY REFLECTING
5 (775) · $ 29.50 · In stock
Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
ASTRAZENECA INDIA INTRODUCES TRASTUZUMAB DERUXTECAN, A PIONEERING TREATMENT FOR HER-2 POSITIVE METASTATIC BREAST CANCER, AstraZeneca, Trastuzumab deruxtecan, Breast Cancer
Gilead splashes out $21B for Immmunomedics, keeping the pedal on new target weeks after AZ-Daiichi deal
Initiatives toward Patient Centricity - Our Approach to Sustanability - Sustainability - Daiichi Sankyo
International Paper Announces Rebrand on 125th Anniversary
Angler Sport Group
The ruined Fukushima nuclear plant leaked radioactive water, but none escaped the facility
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors
Department of Energy Office of Scientific and Technical Information
A new brand identity to bring us into the future
Invida changes name to Menarini Asia-Pacific
ダイヤモンドアンテナ Daiichi Radio Industry Diamond Pass-Through Type SWR Power Meter 1.8-200 MHz SX-200 : Electronics
A new brand identity to bring us into the future
Daiichi Sankyo, Head of Data Governance, R&D: Data Governance and Data Management as a Strategic Asset of a Company
